Shares of Apogee Therapeutics Inc. (APGE) have gained 9.9% over the past four weeks to close the last trading session at $40.98, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $93.88 indicates a potential upside of 129.1%.The average comprises eight short-term price targets ranging from a low of $78 to a high of $116, with a standard deviation of $11.05. While the lowest estima ...

Shares of Concentra Group (CON) have gained 2.9% over the past four weeks to close the last trading session at $22.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28 indicates a potential upside of 27.1%.The average comprises eight short-term price targets ranging from a low of $25 to a high of $30, with a standard deviation of $1.85. While the lowest estimate indicates an ...

Shares of BILL Holdings (BILL) have gained 2% over the past four weeks to close the last trading session at $45.62, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.75 indicates a potential upside of 46.3%.The average comprises 24 short-term price targets ranging from a low of $40 to a high of $120, with a standard deviation of $20.19. While the lowest estimate indicates a de ...

Shares of Birkenstock (BIRK) have gained 4.1% over the past four weeks to close the last trading session at $54.76, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $68.88 indicates a potential upside of 25.8%.The average comprises 17 short-term price targets ranging from a low of $57 to a high of $81, with a standard deviation of $7.34. While the lowest estimate indicates an inc ...

Shares of Monte Rosa Therapeutics (GLUE) have gained 22.5% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.14 indicates a potential upside of 222.2%.The mean estimate comprises seven short-term price targets with a standard deviation of $3.98. While the lowest estimate of $10 indicates a 99.6% increase from ...

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.50 indicates a potential upside of 107.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.09. While the lowest estimate of $5 indicates a 44% decline f ...

The RealReal (REAL) closed the last trading session at $5.71, gaining 13.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.10 indicates a 76.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $3.09. While the lowest estimate of $7 indicates a 22.6% increase from the current price level, the most optimistic analyst expects ...

Shares of ZipRecruiter, Inc. (ZIP) have gained 43.4% over the past four weeks to close the last trading session at $6.25, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8 indicates a potential upside of 28%.The mean estimate comprises five short-term price targets with a standard deviation of $1.87. While the lowest estimate of $6 indicates a 4% decline from the current price ...

Shares of Sagimet Biosciences Inc. (SGMT) have gained 70.6% over the past four weeks to close the last trading session at $5.56, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $29.86 indicates a potential upside of 437.1%.The mean estimate comprises seven short-term price targets with a standard deviation of $20.44. While the lowest estimate of $5 indicates a 10.1% decline from ...

HubSpot (HUBS) closed the last trading session at $609.40, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $763.91 indicates a 25.4% upside potential.The mean estimate comprises 32 short-term price targets with a standard deviation of $66.58. While the lowest estimate of $645 indicates a 5.8% increase from the current price level, the most optimistic analyst expects th ...